Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children’s Oncology Group (COG) report

The ANHL01P1 trial was undertaken to determine pharmacokinetics and safety following the addition of rituximab to French-American-British/ /Lymphome Malins de Burkitt (FAB/LMB96) chemotherapy in 41 children and adolescents with Stage III/IV mature B-cell lymphoma/leukaemia. Patients received rituxim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barth, Matthew J., Goldman, Stanton, Smith, Lynette, Perkins, Sherrie, Shiramizu, Bruce, Gross, Thomas G., Harrison, Lauren, Sanger, Warren, Geyer, Mark B., Giulino-Roth, Lisa, Cairo, Mitchell S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745786/
https://ncbi.nlm.nih.gov/pubmed/23802659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12434
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados